https://endpts.com/amgen-rolls-out-data-for-kras-inhibitor-combo-study-in-colorectal-cancer-hoping-to-move-on-from-ugly-early-results/
Amgen rushing to get their Kras drug into combo studies. It is the only approved Kras drug on the market. This article is a good read. it shows what the drug needs to achieve for an FDA fast track approval.
What a truely exciting period PTX is having at the moment.
Ann: PTX-100 trial advances following successful Phase 1b, page-284
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $37.85M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.6¢ | $54.50K | 1.134M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 108715 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 189091 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PTX (ASX) Chart |